Balaxi Pharma Share Price

₹ 22.20

+₹1.70 (8.29%)
1D
Last updated 05 Nov, 2026, 15:29 IST
NSE: BALAXI
|
Trading

Balaxi Pharma Share Price Today

As of 5 Nov 2026, Balaxi Pharma share price is ₹22.20. The stock opened at ₹20.90, compared to its previous close of ₹20.50. During today's trading session, Balaxi Pharma share price moved in the range of ₹20.77 to ₹22.35, with an average price of ₹21.56 for the day. Looking at its last 52-week, the stock has touched a low of ₹15.20 and a high of ₹43.85. On the performance front, Balaxi Pharma share price has declined by 23.99% over the last six months and is down 52.09% on a year-on-year basis.

Share price over the last 1 day rose from 20.90 to 22.20, ranging between 20.90 and 22.35.
₹20.77
8.29% up today
₹22.35
1D LOW
1D HIGH

Balaxi Pharma Stock Insights

Latest Earning
Op Profit TrendUp by 49.29% QoQ
Latest Earning
Net Profit TrendUp by 113.11% QoQ
Latest Earning
Revenue TrendUp by 8.23% QoQ
Stock Performance
UnderperformingUnderperforming Nifty by 45.4 % in last 1 yr
Balaxi Pharma stock performance
Open₹20.90
High₹22.35
Low₹20.77
Prev. close₹20.50
Balaxi Pharma trading activity
Volume17,898
Average traded price₹21.68
Last traded time03:29:22 05 Nov
Last traded quantity273
Circuit
L
H
₹16.40
₹24.60
52-week
L
H
₹15.20
₹43.85
Mkt Cap Cr
111.85
P/E
46.59
P/B
0.45
ROA
0.72%
ROE
0.57%
ROCE
3.0%
Quick Ratio
2.7
EV/EBITDA
12.25

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Balaxi Pharma has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Balaxi Pharma appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Balaxi Pharma earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,25,150.1638.794.779.61%13.79%18.65%2.3122.17
Divis Laboratories2,66,424.2791.0915.914.6%15.32%19.56%3.560.7
Torrent Pharmaceuticals1,76,300.5085.729.794.7%11.42%11.37%0.7533.85
Laurus Labs1,25,352.4494.0820.6811.58%22.11%20.91%0.6853.48
Zydus Lifesciences1,18,702.9627.594.278.08%18.59%17.35%0.9116.36
Dr. Reddy's Laboratories1,14,351.2041.52.954.79%7.21%8.58%1.3519.27
Cipla1,12,471.7539.633.26.6%8.18%10.8%2.521.31
Mankind Pharma1,02,315.4046.235.957.82%12.76%14.68%0.7424.84
Aurobindo Pharma97,756.7126.382.586.34%9.25%11.76%1.1512.48
Lupin92,144.5417.653.8313.91%23.76%24.88%1.429.85

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Balaxi Pharma Company Background

ISIN
INE618N01022
Sector Market Cap
₹ 111.85 Cr

Balaxi Pharmaceuticals Limited is an India-based company. The Company operates as an intellectual property right (IPR)-based pharmaceutical company. The Company primarily operates in frontier markets across the Americas, Africa and the Caribbean islands. The Company is focusing on frontier markets, with a growing portfolio of drugs across multiple therapeutic segments. It is engaged in International Wholesale Distribution of Pharmaceuticals. The Company’s products include Anti-biotic, Analgesic, Medical Device, Vitamins, Anti-Malaria, Erectile Dysfunction, Hypertension, Anti-Asthma, Steroid, Anti-Helminthic, Anti-Ulcer, Hygiene, Anticholinergic, Dietary Supplement, Diuretic, Hormone, Anti-Emetic, Bronchodilator, Local Anesthetic, Anemia, Anti-Diarrhea, Antihistamine, Hypotension, Antacid, Anti-Tuberculosis, Insect Repellents, and Laxative. Its Boadent brand includes anticavity dental toothpaste. Its subsidiaries are Balaxi Global DMCC, Dubai and Balaxi healthcare Ecuador.

Balaxi Pharma Financial Highlights

  • Revenue: Balaxi Pharma reported revenue of ₹272.99 crore in FY26 vs ₹288.84 crore in FY25. It showed a decrease of 5.49% on a yearly basis.
  • Operating Profit: Balaxi Pharma reported an operating profit of ₹5.29 crore in FY26 vs ₹28.67 crore in FY25. It showed a decrease of 81.55% on a year-on-year basis.
  • Net Profit: Balaxi Pharma reported a net profit of ₹1.42 crore in FY26 vs ₹25.07 crore in FY25. It showed a decrease of 94.34% on a yearly basis.

Balaxi Pharma Quarterly Result Highlights

  • Balaxi Pharma reported revenue of ₹79.69 crore in Jun 2026, compared with ₹73.63 crore in Mar 2026, representing an increase of 8.23% on a quarter-on-quarter (QoQ) basis.
  • Balaxi Pharma reported an operating profit of ₹2.09 crore in Jun 2026, compared with ₹1.40 crore in Mar 2026, representing an increase of 49.29% on a quarter-on-quarter (QoQ) basis.
  • Balaxi Pharma reported a profit of ₹1.30 crore in Jun 2026, compared with ₹0.61 crore in Mar 2026, reflecting an increase of 113.11% on a QoQ basis.
  • The earnings per share (EPS) of Balaxi Pharma stood at ₹0.26 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
65.99%
FII
0.00%
Other DII
2.56%
Retail and other
31.45%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20251.74%
Mar 20260.00%
Jun 20260.00%
Sep 20260.00%

Balaxi Pharma Investment Returns

1 day
+1.18%
1 week
+0.84%
1 month
-8.24%
1 year
-52.09%
3 years
-75.40%
5 years
-82.35%

Balaxi Pharma Share Price History

Balaxi Pharma share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
04 Nov 26
₹19.75 / ₹20.50
+1.18%
03 Nov 26
₹19.75 / ₹20.26
+2.58%
02 Nov 26
₹19.60 / ₹19.75
+3.13%
30 Oct 26
₹19.99 / ₹19.15
-2.84%
Show more

Balaxi Pharma Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹270.17₹292.56₹241.29₹336.43
Other Income₹2.82-₹3.72₹0.63₹2.64
Total Revenue₹272.99₹288.84₹241.93₹339.07
Total Expenses₹267.70₹260.18₹201.62₹282.15
Profit Before Tax₹5.29₹28.67₹2.02₹56.92
Tax₹3.88₹3.60₹4.40₹10.96
Profit After Tax₹1.42₹25.07-₹2.39₹45.96
EPS - Basic₹0.26₹4.54-₹0.46₹45.81
EPS - Diluted₹0.26₹4.54-₹0.46₹45.40

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹5.29₹28.67₹2.02₹56.92
Income before WC changes₹27.27₹36.10₹0.87₹64.96
Change in Assets-₹32.90-₹55.02₹14.35-₹31.74
Change in Liabilities₹5.85-₹12.87-₹3.67-₹15.05
Change in WC-₹27.05-₹67.89₹10.68-₹46.79
Cash flow from Operations-₹4.50-₹35.00₹4.87₹6.08
Cash flow from Investing-₹20.78-₹21.76-₹1.05-₹10.57
Cash flow from Financing₹0.44₹33.88₹30.25₹25.51
Total Cash Flow-₹24.84-₹22.89₹34.07₹21.02
Cash (Start of the year)₹39.40₹62.29₹28.21₹7.19
Cash (End of the year)₹14.56₹39.40₹62.29₹28.21

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹85.60₹67.58₹48.17₹46.16
Current Assets₹251.43₹242.77₹210.17₹193.51
Total Assets₹337.03₹310.34₹258.34₹239.67
Current Liabilities₹62.16₹54.53₹54.20₹53.13
Net Current Asset₹189.27₹188.23₹155.97₹140.38
Non-Current Liabilities₹25.80₹24.07₹2.78₹3.66
Equity Capital₹249.08₹231.74₹201.36₹182.88
Total Equity & Liabilities₹337.03₹310.34₹258.34₹239.67

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹80.85₹60.99₹70.20₹108.14
Other Income₹9.67₹5.37₹2.40₹6.60
Total Revenue₹90.52₹66.36₹72.59₹114.74
Total Expenses₹83.49₹61.07₹67.01₹92.29
Profit Before Tax₹7.03₹5.29₹5.58₹22.45
Tax₹1.89₹1.69₹1.93₹6.23
Profit After Tax₹5.15₹3.60₹3.65₹16.22
EPS - Basic₹0.93₹0.65₹0.71₹16.17
EPS - Diluted₹0.93₹0.65₹0.71₹16.02

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹7.03₹5.29₹5.58₹22.45
Income before WC changes₹10.43₹7.80₹7.63₹23.43
Change in Assets₹25.98-₹10.93₹0.57-₹27.37
Change in Liabilities₹9.16-₹2.84-₹4.96₹2.29
Change in WC₹35.14-₹13.77-₹4.39-₹25.08
Cash flow from Operations₹43.87-₹7.60-₹1.83-₹7.07
Cash flow from Investing-₹67.77-₹24.98₹0.46-₹2.29
Cash flow from Financing₹0.54₹17.21₹27.55₹26.39
Total Cash Flow-₹23.35-₹15.37₹26.19₹17.03
Cash (Start of the year)₹28.68₹44.06₹17.87₹0.84
Cash (End of the year)₹5.33₹28.68₹44.06₹17.88

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹121.57₹54.84₹31.46₹30.70
Current Assets₹70.60₹119.60₹122.90₹99.02
Total Assets₹192.17₹174.45₹154.36₹129.72
Current Liabilities₹55.73₹43.76₹30.04₹34.83
Net Current Asset₹14.87₹75.84₹92.86₹64.19
Non-Current Liabilities₹3.44₹2.83₹2.78₹2.79
Equity Capital₹133.00₹127.85₹121.55₹92.11
Total Equity & Liabilities₹192.17₹174.45₹154.36₹129.72
* All values are in INR Crore
Balaxi Pharma market depth
Bid quantityBid priceAsk priceAsk quantity
221.8900
0000
0000
0000
0000
Total bid quantity2
Total ask quantity0
Balaxi Pharma technical summary
Bearish indicators4
Neutral indicators4
Bullish indicators0
OverallStrong Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
46.23
Neutral
ATR (14)
1.27
Neutral
STOCH(9,6)
88
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
46.51
Bearish
UO(9)
52.92
Neutral
ROC(12)
-5.39
Bearish
WillR(14)
-43.88
Neutral
Period
Simple value
Exponential vaue
5D
19.95
20.28
10D
20.19
20.42
20D
21.13
20.97
50D
22.38
22.02
100D
23.09
22.61
Volume trend — traded volume by day
5 Nov0L
4 Nov0L
3 Nov0L
2 Nov0L
30 Oct0L
29 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Balaxi Pharma
Trading
Add Stock
Add Another

Balaxi Pharma Returns Calculator

Top Gainers

UNOMINDA Share Price
₹1335.00
+138.1 (+11.54%)
ASHOKLEY Share Price
₹170.21
+16.18 (+10.5%)
DEVYANI Share Price
₹129.21
+10.53 (+8.87%)
SOBHA Share Price
₹1291.90
+103.9 (+8.75%)
FIVESTAR Share Price
₹429.85
+32.7 (+8.23%)
See more

Top Losers

PIIND Share Price
₹1770.00
-417 (-19.07%)
CUMMINSIND Share Price
₹4058.90
-666.8 (-14.11%)
APTUS Share Price
₹179.93
-26.35 (-12.77%)
GMMPFAUDLR Share Price
₹1194.20
-126 (-9.54%)
CHENNPETRO Share Price
₹1418.50
-148.4 (-9.47%)
See more

Balaxi Pharma Share Price FAQs

Please be aware that Balaxi Pharma stock prices are subject to continuous fluctuations due to various factors.